Print

Cytel Inc.-Designed Adaptive Confirmatory Study Poster Accepted at American Society of Clinical Oncology 2011  
5/23/2011 8:49:08 AM

Cytel Inc., the premier provider of adaptive clinical trial services and biostatistical software, today announced that a jointly authored review of Sunesis Pharmaceuticals’ VALOR trial adaptive design will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting.
//-->